Close

Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

×

Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Pharmacy compliance director pleads guilty over mislabeled drugs

Jaclyn Jaeger | November 27, 2017

The former director of compliance for a compounding pharmacy company pleaded guilty last week to introducing adulterated drugs into interstate commerce and conspiracy to defraud the United States by obstructing the Food and Drug Administration’s lawful functions.

Caprice Bearden pleaded guilty in the Southern District of Indiana to one count of conspiracy to defraud the United States, three misdemeanor counts of introducing an adulterated drug in interstate commerce, and six misdemeanor counts of adulterating drugs while held for sale after shipment of a drug component in interstate commerce. Bearden was the compliance director for Pharmakon Pharmaceuticals, which compounds drugs at a facility in Indiana for customers in various states.

Chief U.S. District Judge Jane Magnus-Stinson accepted Bearden’s plea. A date for sentencing has...

Buy this article for $49, or subscribe to Compliance Week for a month at $149 and get unlimited article access for 30 days.